COVID-19: Physician co-authors analysis of antiviral drug

In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral drug remdesivir, clinical improvement was observed in 68% of patients treated, according to an analysis ...

Diseases, Conditions, Syndromes

Adding tirzepatide to insulin glargine ups glycemic control in T2DM

(HealthDay)—The addition of subcutaneous tirzepatide versus placebo to titrated insulin glargine results in significant improvements in glycemic control among patients with type 2 diabetes and inadequate glycemic control, ...


Vagus nerve stimulation promising in Crohn's disease

(HealthDay)—Vagus nerve stimulation may represent a new therapeutic option for patients with Crohn's disease (CD), according to a report published online April 18 in the Journal of Internal Medicine.

page 1 from 11